كل ما تود معرفته عن pfizer

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken in Medford, Massachusetts, U.S., May 12, 2022. REUTERS/Brian Snyder/Illustration

U.S. Government to Test Pfizer's Paxlovid For Long COVID

The U.S. National Institutes of Health's $1 billion RECOVER Initiative has picked Pfizer Inc's (PFE.N) antiviral drug Paxlovid as the first treatment it will study in patients with long COVID,…

27 October 2022

Pfizer To Supply Up To 6 mln COVID Pill Courses For Lower Income Countries

Pfizer Inc (PFE.N) said it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seek to address worldwide disparities…

23 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

Axel Rangel Garcia

Politics

The UN is dead: Chemillier-Gendreau on the collapse of international law

13 January 2026

In an interview with Al Majalla, the prominent French jurist discusses Israeli and Western duplicity, their violation of international law, and why Israel bears the cost of Gaza's reconstruction

Elie Kossaifi

Opinion

Iran's regime may not be falling, but it is fading

16 January 2026

Tehran's elite have few friends, but regional states fear the consequences of a disorderly transition. If Iran's 92 million people turn on one another, it could cause millions to flee abroad.

Omer Onhon

Al Majalla

Politics

Trump's retreat from multilateralism throws up a host of challenges

14 January 2026

Going forward, the international community needs to reduce dependence on the US without upsetting the world's largest military and economic power. It will be a shaky tightrope to walk.

Ramzy Ezzeldin Ramzy

Yasser Al-Rumayyan, Governor of the Public Investment Fund, delivers a speech during the third edition of the Future Investment Initiative, in Riyadh on 28 October 2025.

AFP

Business & Economy

Saudi Arabia loosens restrictions on foreign investors

12 January 2026

Scrapping foreign ownership caps and qualifying criteria will bring in more capital, with markets reacting positively to the latest reforms that build towards a more open country

Sharif Mohammad